(ETON) Eton Pharmaceuticals - Performance 381.4% in 12m
Compare ETON with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
45.52%
#25 in Group
Rel. Strength
99.56%
#36 in Universe
Total Return 12m
381.43%
#2 in Group
Total Return 5y
209.17%
#9 in Group
P/E -
(?) Percentile in Group
P/E Forward 34.1
73th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 0.24%
43th Percentile in Group
12m Total Return: ETON (381.4%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: ETON vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ETON
Total Return (including Dividends) | ETON | XLV | S&P 500 |
---|---|---|---|
1 Month | 29.82% | -3.79% | -0.87% |
3 Months | -4.69% | -3.99% | -7.58% |
12 Months | 381.43% | 1.72% | 11.88% |
5 Years | 209.17% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | ETON | XLV | S&P 500 |
1 Month | 88.6% | -3.2% | 23% |
3 Months | -52.2% | -71.4% | -88.5% |
12 Months | 91.7% | -17.5% | 55.1% |
5 Years | -11.9% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #15 | 34.9% | 31.0% |
3 Month | #77 | -0.74% | 3.12% |
12 Month | #2 | 373% | 330% |
5 Years | #9 | 99.0% | 47.0% |
FAQs
Does ETON Eton Pharmaceuticals outperforms the market?
Yes,
over the last 12 months ETON made 381.43%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months ETON made -4.69%, while XLV made -3.99%.
Over the last 3 months ETON made -4.69%, while XLV made -3.99%.
Performance Comparison ETON vs Indeces and Sectors
ETON vs. Indices ETON is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 5.28% | 30.7% | 101% | 370% |
US NASDAQ 100 | QQQ | 4.25% | 28.4% | 100% | 369% |
US Dow Jones Industrial 30 | DIA | 6.22% | 33.0% | 101% | 372% |
German DAX 40 | DAX | 6.51% | 28.5% | 81.3% | 357% |
Shanghai Shenzhen CSI 300 | CSI 300 | 9.24% | 32.6% | 104% | 375% |
Hongkong Hang Seng | HSI | 6.27% | 29.8% | 98.9% | 368% |
India NIFTY 50 | INDA | 8.12% | 25.8% | 101% | 378% |
Brasil Bovespa | EWZ | 6.08% | 25.2% | 97.1% | 387% |
ETON vs. Sectors ETON is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 5.03% | 30.9% | 94.7% | 357% |
Consumer Discretionary | XLY | 5.20% | 29.9% | 98.3% | 368% |
Consumer Staples | XLP | 8.78% | 29.6% | 95.5% | 370% |
Energy | XLE | 9.76% | 43.7% | 107% | 393% |
Financial | XLF | 6.67% | 31.9% | 93.2% | 359% |
Health Care | XLV | 5.36% | 33.6% | 102% | 380% |
Industrial | XLI | 4.86% | 29.7% | 100% | 372% |
Materials | XLB | 5.89% | 32.3% | 108% | 385% |
Real Estate | XLRE | 6.80% | 31.1% | 102% | 363% |
Technology | XLK | 2.83% | 28.1% | 104% | 374% |
Utilities | XLU | 8.12% | 29.8% | 98.7% | 360% |
Aerospace & Defense | XAR | 4.33% | 23.4% | 87.3% | 355% |
Biotech | XBI | 3.98% | 27.5% | 113% | 383% |
Homebuilder | XHB | 5.97% | 32.1% | 116% | 388% |
Retail | XRT | 6.85% | 30.4% | 106% | 384% |